Generic Oncology Drugs Market is Poised to Surpass a Stunning CAGR of 6.2% Through 2028

Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of growth for the generic oncology drugs market and the cost pertaining to the treatment of cancer. Advanced technologies such as real world data, mobile apps, and artificial intelligence have successfully been able to achieve a high engagement rate of the patients, which has resulted in increasing awareness of the cancer treatment among the patients.

A significant increase has been noted in the spending capacity for the development of cancer. More than one-third of the trials proposed by the manufacturers are aimed at offering personalized cancer treatments, which further propels the demand for generic oncology drugs. A host of these factors have contributed massively to the expansion of the generic oncology drugs market at the global level.

According to a report, the global generic oncology market is poised to surpass a striking CAGR of 6% through 2028. Increasing inclination of individuals towards smoking and tobacco consumption is the chief cause of cancer. Secondary factors such as sedentary lifestyle, genetic causes, viral infections, carcinogens, and high consumption of junk food make the human body susceptible to cancer. Growing concerns of a high number of deaths occurring on the back of cancer have provoked the government authorities to take effective steps for preventing cancer.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-8961

Notable Developments in the Generic Oncology Drugs Market

Improvement in the cancer treatment drugs and therapies have been one of the most underlying aims of the pharmaceuticals and medical organizations operating at the global level. Consequently, generic oncology drugs have been utilized for innovating novel therapies and increasing the survival rates of patients.

Blood Cancer Immensely Contributes to the Growth of the Generic Oncology Drugs Market

Amongst the various types of cancer such as skin cancer, bladder cancer, bone cancer, eye cancer, gastrointestinal cancer, gynecological cancer, lung cancer, endocrine cancer, and blood cancer is accounted for generating the largest share for the generic oncology drugs market. Patients diagnosed with blood cancer seek complete treatment to this chronic disease, as a result of which excessive demand for generic oncology drugs is created. In addition to this, the high cost of the therapies and generic oncology drugs play a crucial role in the growing size of the generic oncology drugs market.

Preview Analysis of Generic Oncology Drugs Market is segmented by (Molecule Type – Large Molecule & Small Molecule; Route of Administration – Oral & Parenteral; Distribution Channel – Hospital Pharmacy, Retail Pharmacy, Online Pharmacy & Managed Care Institutions;) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018-2028: https://www.futuremarketinsights.com/reports/generic-oncology-drugs-market

Recent Developments to Drive the Growth of the Generic Oncology Drugs Market

The key players involved in transforming the landscape of the generic oncology drugs market include Bayer Healthcare AG, Amgen, Teva Pharmaceutical Industries, Pfizer, Boehringer Ingelheim GmbH, AstraZeneca, Hoffmann-La Roche Ltd., Eli Lily and Company, ARIAD Pharmaceuticals, Inc., GlaxoSmithKline, CELGENE Corporation, Novartis AG, Johnson and Johnson, AbbVie Inc., Merck & Co., and Sanofi, among others.

Out of these leading players, CELGENE, Novartis, and Roche have been procuring a considerable share in the generic oncology drugs market with a rich product portfolio and pipeline products aimed at treating cancer effectively.

  • Novartis AG applied smart strategies for channel integration like eCommerce with mobile application to fuel the sales at the retail stores. In addition to this, the company achieved a CE mark for its gene modifying therapy used for the treatment of blood cancer.
  • Pfizer Inc. has been focusing on the over 39 therapies, in order to fortify its product portfolio. In the year 2017, Glasdegib of Pfizer received the priority review from the U.S. FDA to treat myeloid leukemia. Post this, XTANDI of Pfizer as well received the FDA approval.

Many similar key development shaping the landscape of the existing generic oncology drugs market have been incorporated in the report.

For more information, send an email to press@futuremarketinsights.com

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/customization-available/rep-gb-8961

More from Healthcare, Pharmaceuticals and Medical devices Market Intelligence:

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Dental X-ray Systems Market will grow at a striking CAGR of over 6% by the end of 2026

Increasing incidences of acute diseases like cancer has created a robust demand for effective diagnostics and treatment for the early detection of this disease and increase the probability of survival. As a result, dental X-ray systems have witnessed a rapid rise in their demand, on the back of their qualification as a promising diagnostics and treatment procedure. In addition to this, the dental X-ray systems significantly reduce the radiation dose among the patients, which strengthens the trust of the medical practitioners in the equipment and boosts the growth of the dental X-ray systems market.

Rising geriatric population and their edentulous issues directly open lucrative opportunities for the dental X-ray systems market. Moreover, healthcare facilities utilized by the elderly population are subsidized by the government, which in turn, has boosted the usage of dental X-ray systems. According to a report published by Future Market Insights (FMI) opines that the global dental X-ray systems market will grow at a striking CAGR of over 6% by the end of 2026.

With the increasing comfort provided by the portable intraoral X-ray systems, the traditionally used floor mounted dental X-ray systems are gradually becoming obsolete. When weighted on the basis of cost, dental X-ray systems provides far better affordability to the dental clinics and hospitals as compared to the cone-beam computed tomography (CBCT) systems, which is why the sales prospects of the former are better.

“To remain ‘ahead’ of your competitors, request for a sample” – https://www.futuremarketinsights.com/reports/sample/rep-gb-8960

Challenges Pertaining to the Dental X-ray Systems Market: Reduction in Reimbursement

A notable reduction in the primary healthcare facilities for many diseases including oral health will affect the capacity and the resources adversely. Newly formed legislation will enforce reduced reimbursement regulations on the MPFS (Medicare Physician FEE Schedule) and HOPPS (Hospital Outpatient Prospective Payment System), which is expected to cause a drop in the growth of the dental X-ray systems market.

Technological Advancements to Lend Ample Growth Opportunities to the Dental X-ray Systems Market

Innovations and advancements brought about in the medical imaging vicinity and especially, dental X-ray systems have intensified the growth prospects of the dental X-ray systems market. Owing to the progress made by the healthcare industry, there has been a consistent need for the precise diagnosis of the diseases, which has been fulfilled by the dental X-ray systems. Given the multifold applications of these systems, the global dental X-ray systems market is projected to grow exponentially.

North America to Maintain a Strong Hold on the Global Dental X-ray Systems Market

The study on dental X-ray systems market provides a detailed analysis on the basis of several factors affecting the market growth. The key geographies assessed in this study include China, APEC, Europe, Latin America, North America, and Middle East and Africa (MEA). Depending on the market size, North America leads the dental X-ray systems market, attributed to the advanced healthcare facilities and excellent spending capacity. As a subsequence, the regional dental X-ray systems market is expected to bear positive results for the global dental X-ray systems market.

Following the footsteps of North America, Europe is the second most dominating region influencing the growth of the dental X-ray systems market. In addition to this, Asia Pacific is equally estimated to contribute to the growing market size during 2018 – 2026.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-8960

Collaboration and Mergers to Trigger the Growth of the Dental X-ray Systems Market

The report on the dental X-ray systems market includes a comprehensive analysis of the companies devising innovative solutions in the market.

The leading players incorporated in the report are

FONA, J.

MORITA CORP.,

Danaher Corporation,

PLANMECA OY,

Prexion Corporation,

Carestream Dental,

LLC,

Owandy Radiology,

Vatech Co. Ltd.,

The Yoshida Dental Mfg. Co. Ltd.,

Dentsply Sirona,

LED Medical Diagnostics Inc.,

Cefla S.C., and Air Techniques, Inc., among others.

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-8960

Key Segment

Based on the product type

Cephalometric Projections Systems

Portable Intraoral X-ray Systems

Panoramic X-ray Systems

Intraoral X-ray Systems Mounted on the Floor

Based on the geographies

North America

Europe

Latin America

Middle East & Africa (MEA)

China

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

IP Multimedia Subsystem (IMS) Market is anticipated to grow at a pronounce rate and bring in US$ 50,347.4 Million in revenues by 2026

[236 Pages Report] Future Market Insights (FMI) recently published a report on the global market for IP multimedia subsystem, findings from which assert that the market will surge at an impressive pace over the forecast period (2016-2026). Demand for IP multimedia subsystem is anticipated to grow at a pronounce rate and bring in US$ 50,347.4 Mn in revenues by 2026-end, reflecting a CAGR of 15% during the forecast period. Increasing use of shared service infrastructure is cited as a key factor propelling growth of the global IP multimedia subsystem market. In addition, interworking with Internet and support for quality of service is also likely to drive the demand for IP multimedia subsystem in the near future.

As per the FMI report, the global market for IP multimedia subsystem is expected to represent an incremental opportunity of US$ 37,927.6 Mn between 2016 and 2026. The market is anticipated to witness overwhelming growth owing to the increasing usage of services such as instant messaging, multimedia, and conferencing. Moreover, enterprises are now using IP multimedia subsystem to communicate with other business clients in real-time. IP multimedia subsystems enable service expansion, especially in multimedia communication and integrated voice services. This helps in collaboration of multiple media, multiple points of access and multiple modes of communication into a single network, which is why a large number of network operators are adopting IMS services. Mitel Networks Corporation, Cirpack SAS, Italtel S.p.A, Cisco Systems, Inc., Huawei Technologies Co. Ltd., Du, IBM Corporation, ZTE Corporation, Etisalat, Ericsson Inc., Nokia Corporation, MTN Irancell Telecommunication Services Company are recognised as top companies providing IP multimedia subsystem solutions.

ip multimedia subsystem market

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2361

Key Highlights of the Report include:

  • In 2016, revenues from the sale of mobile/wireless mode IP multimedia subsystem stood at US$ 8,687.9 Mn and is expected to reach US$ 40,931.3 Mn towards the end of the forecast period representing a CAGR of 20.8%. Consumers and enterprises are increasingly adopting IP multimedia subsystem solutions due to increasing usage of wireless phones, laptops and other wireless devices.
  • Application of IP multimedia subsystem in Internet and web service is expected to garner US$ 14,579.8 Mn in revenues by the end of the assessment period, reflecting a CAGR of 17.2% over 2026. This is attributed to the robust use of internet and web-based services for managing online business applications, VoIP applications, VoLTE applications and others Internet-based communication. Meanwhile, use of IP multimedia subsystem in VoIP is also increasing owing to the growing popularity of video and voice-based communication.
  • By the end of 2026, US$ 28,283.7 Mn worth IP multimedia subsystems are expected to be sold globally to end-user consumers. Consumers are rapidly adopting IP multimedia subsystem services owing increasing adoption of social media platforms for social and personal communication.

Among regions, the market for IP multimedia subsystems in North America is expected to remain dominant throughout the forecast period. In 2016, the region’s market reached a valuation of US$ 3,318.2 Mn, with 26.7% revenue share.  APEJ is also expected to witness a robust growth of its IP multimedia subsystems market, increasing at an attractive CAGR of 18.5 % during the forecast period.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2361

Market TaxonomyBy Mode of Communication

  • Mobile/Wireless
  • Cable/Wireline

By End User

  • Consumer
  • Enterprise

By Application

  • Internet & Web Service
  • VoIP
  • SMS
  • Video Conferencing
  • Video on Demand
  • Others

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Middle East and Africa
  • Japan

Automotive ABS and ESC Market has been estimated to surpass US$ 100,000 Mn in revenues by 2022-end

A recent research report delivered by Future Market Insights (FMI) has projected the global market for automotive ABS and ESC to exhibit an undulating expansion over the forecast period, 2017 to 2022. Global sales of automotive ABS and ESC has been estimated to surpass US$ 100,000 Mn in revenues by 2022-end.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5292The automotive industry is currently being propelled by hi-tech innovation, being more inclined toward adoption of advanced technologies for reducing crashes and mitigating impact of accidents on passengers. Automotive safety systems, such as ABS and ESC, are therefore gaining immense traction among consumers across the globe. Leading manufacturers of ABS and ESC systems are adopting strategic approaches such as mergers & acquisitions and new product launches, with an aim of expanding their product line and maintaining their instrumental position in the market.

Europe and North America – Most Lucrative Markets for Automotive ABS and ESC

In regions such as Europe and North America, automotive ABS and ESC systems have a high penetration rate and are well established. In terms of revenues, Europe and North America will continue to be the most lucrative market for automotive ABS and ESC. The market in North America is projected to register the highest CAGR through 2022.

Asia-Pacific excluding Japan (APEJ) is also expected to be a major lucrative market for automotive ABS and ESC, with revenues estimated to exceed US$ 25,000 Mn in revenues by 2022-end. Growth of the automotive ABS and ESC market in APEJ can be highly attributed to increasing consumer preferences for better safety systems in vehicles, along with the introduction of legislation & policy framework that mandates integration of safety equipment in vehicles.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-5292

OEMs to Account for Over 90% Revenue Share of Global Automotive ABS and ESC Market during 2017 to 2022

Automotive braking systems with improved vehicle safety and requirement of minimum maintenance, such as the ABS and ESC, introduced by OEMs have created the breakthrough developments in the market. OEMs will account for over 90% revenue share of the automotive ABS and ESC market during 2017 to 2022.

Whether in light of outlaw status of ABS and ESC, or street market liability concerns in most of the vehicles, aftermarket has failed so far in developing even a basic ABS or ESC system. However, sales of ABS and ESC systems in aftermarket are projected to register an above-average expansion through 2022, although estimated to account for a very low revenue share of the market over the forecast period.

Compact Vehicles to Account for Nearly One-Third Market Revenue Share throughout the Forecast Period

Sales of automotive ABS and ESC are forecast to register the fastest expansion in compact vehicles, followed by light commercial vehicles and heavy commercial vehicles. Nearly one third revenue share of the market is projected to be accounted by automotive ABS and ESC sales in compact vehicles throughout the forecast period. In addition, sales of automotive ABS and ESC in mid-sized vehicles are also projected to record a robust expansion through 2022.

Pre-Book Report @ https://www.futuremarketinsights.com/checkout/5292

Market Taxonomy

Region

  • North America
  • Latin America
  • Europe
  • Japan
  • APEJ
  • MEA

Technology Type

  • Three Channel ABS
  • Four Channel ABS
  • ESC

Vehicle Type

  • Compact Vehicle
  • Mid-Sized Vehicle
  • Premium Vehicle
  • Luxury Vehicle
  • Commercial Vehicle
  • Heavy Commercial Vehicle

Sales Channel

  • OEM
  • Aftermarket

ESC technology in the global automotive ABS and ESC market will remain preferred among consumers. Revenues from sales of ESC technology in vehicles are forecast to account for nearly one-fourth share of the market in 2017. Demand for ESC technology will further witness an upsurge over the forecast period. The largest revenue share of the market has been anticipated to be accounted by three channel ABS technology, with sales poised to expand at approximately 10% CAGR through 2022. Sales of four channel ABS technology will continue to witness a relatively slower expansion than three channel ABS and ESC technology segments through 2022.

Radiation Proctitis Treatment Market Competitive Growth Strategies Based on Type, Applications, End User and Region

Radiation proctitis is a complication which occurs after a radiation therapy for treatment of pelvic malignancy. Most of the cases of radiation proctitis are treated without surgery. The complication involves inflammation of the lower part of the colon, apoptosis, damage of DNA, proteins among many more complications. The most common symptom of radiation proctitis is rectal bleeding.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12844

The COVID-19 pandemic has caused ripples in all the industrial sectors including healthcare. The effects of this on the global radiation proctitis treatment market would also be felt.

The effects however, might not be hugely impactful. Some effects could be suspension of manufacturing process, delay in raw material procurement, delay in supply chain logistics, shortage of labor.

COVID-19 burden on the hospitals might also result in various effects like diversion of funds and staff to deal with COVID patients which would eventually affect the global radiation proctitis treatment market.

Radiation Proctitis Treatment Market: Drivers and Restraints

The major driver for the global radiation proctitis treatment market if the growing prevalence of rectal, prostate and cervical cancer. Another driver in the market of radiation proctitis treatment is growing adoption of radiation therapy to treat the above mentioned conditions.

Various collaborations to investigate better treatment options for prostate, rectal or cervical cancer may in long run hamper the growth of global radiation proctitis treatment market. Lack of awareness and resources in the developing world would further add to the restraints for the global radiation proctitis treatment market.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12844

Radiation Proctitis Treatment Market: Overview

The global radiation proctitis treatment market is set to register robust growth owing to the increased incidences of various cancers like cervical, prostate, and rectal. Prostate cancer is the second most common cancer and is fifth most cause of death in the world. Based on the type segmentation, sucralfate drugs sub-segment is expected to register robust growth in the radiation proctitis treatment market, as these contain high sulfated polyanionic disaccharide compound resulting in epithelial healing and forming a coat that facilitates quick healing. Based on the distribution channel, hospital pharmacies can be estimated to hold the majority of share in the global radiation proctitis treatment market since these drugs are mostly taken under medical supervision.

Radiation Proctitis Treatment Market: Region-wise Outlook

North America can be estimated to dominate the global radiation proctitis treatment market based on high prevalence of rectal cancer and prostate in the region. Europe may be estimated to hold the second major share in the global market of radiation proctitis treatment.

This is based on the fact that the incidence rate of prostate cancer in the region is 62.1%. Middle East and Africa is expected to hold least share in the global radiation proctitis treatment market. Increase in radiation therapy for cancer treatment in the regions of Asia is expected to boost the global radiation proctitis treatment market in the region.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-12844

Radiation Proctitis Treatment Market: Key Players

The key players for the global radiation proctitis treatment market are

  • Dr. Reddy Laboratories,
  • Chugai Pharmaceutical Co Ltd.,
  • Nanjing Pharmaceutical Factory Co., Ltd.,
  • GlaxoSmithKline,
  • Allergan,
  • Northeast Pharmaceutical,
  • Reckitt & Benckiser,
  • Huanan Pharma
  •  Sun Pharmaceutical Industries

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Automotive Cylinder Liner Market is estimated to reach ~US$ 4 Bn in 2019, and increase at a CAGR of ~4% during the projected period of 2019-2029

Future Market Insights has recently published a new market research study on the automotive cylinder liner market that Contains global industry analysis 2014–2018 and opportunity assessment 2019–2029. The report investigates the automotive cylinder liner market and provides critical insights for the forecast period of 2019-2029. As per the key findings of the report, the global automotive cylinder liner market is expected to witness considerable growth in upcoming years due to the increasing implementation of emission norms, coupled with downsizing of engines, resulting in the increase in demand for light weight automotive cylinder liners.

The global automotive cylinder liner market is estimated to reach ~US$ 4 Bn in 2019, and increase at a CAGR of ~4% during the projected period of 2019-2029. This growth is expected to be mainly driven by the increasing demand for passenger and commercial vehicles across the globe.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3387

Emergence of High-Quality Automotive Cylinder Liners Expected to Drive the Market in APAC

Sales of automotive cylinder liners are directly related to the production of automobiles. China, being one of the prominent manufacturers in the automotive industry, is expected to account for a prominent share in the global automotive cylinder liner market. The emergence of innovative, high-quality, and cost-effective products is expected to drive the market growth in the region. To enhance the durability and efficiency of engine, new materials have been developed, which are more efficient than the traditionally used in cylinder liners. In addition to rising number of regional players in Asian Pacific countries including China and India, key players are targeting the region for improved customer base and increased geographical footprint. Furthermore, in India, the government provides an extensive support to farmers to purchase agricultural equipment and work more efficiently. The Indian government offers crop loans, credit schemes, and subsidized interest rates, which boost the demand for agricultural vehicles, in turn, increasing the demand for automotive cylinder liners.

Growing Electric Mobility to Impede the Market Growth  

The dependency of consumers on conventional cylinder liners is now shifting. Consumers’ preference is expected to shift from conventional vehicles to electric vehicles, which is expected to create a hindrance in the growth of the automotive cylinder liner market across the globe. A large production of electric vehicles in the Asia Pacific region is supporting the penetration of electric vehicles in the fuel-driven conventional automobile market. Increasing preference for electric vehicles, which are environment friendly, safe, and easy to handle, is likely to hamper the growth of the automotive cylinder liner market in the Asia Pacific region

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-3387

Automotive cylinder Liner Market: Taxonomy

Vehicle Type

  • Light Duty
  • Heavy duty

Liner Type

  • Dry Liner
  • Wet Liner

Material Type

  • Cast Iron
  • Aluminium Alloys
  • Steel
  • Titanium

Application

  • Diesel Engine
  • Gasoline Engine

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • MEA
  • Japan

Automotive Cylinder Liner Market: Vendor Insights

The report highlights some of the prominent market players, who have established themselves as leaders in the global automotive cylinder liner market. Few examples of key players in the market are Federal-Mogul LLC, Mahle GmbH, Nippon Piston Rings Co. Ltd., ZYNP Corporation, India Pistons Ltd., TPR CO., LTD., Bergmann Automotive GmbH, Westwood Cylinder Liner Ltd., Aichi Machine Industry Co., Ltd. among others.The global automotive cylinder liner market is considered to be significantly fragmented one. Global players falling under Tier-1 category accounts for ~20% of the overall market share, whereas medium-sized and small-sized players are expected to be prominent in the global market. Tier-1 players are focusing on investing in new technology that would contribute to reduce the weight of the engine.

Direct Purchase of this Report@ https://www.futuremarketinsights.com/checkout/3387

Automotive Cylinder Liner Market – Key Research Findings

  1. The global automotive cylinder liner market size in 2019 is ~US$ 4 Bn.
  2. The automotive cylinder liner market is estimated to grow at a CAGR of ~4 % over the forecast period of 2019-2029.
  3. Use of automotive cylinder liner in light duty vehicles is likely to result in increased market share during the forecast period.
  4. In countries, such as India, China, France, U.K., and Spain, the growing production of passenger cars is resulting in significant growth of the automotive cylinder liner market. The APEJ region generates high demand for agriculture equipment as well as construction equipment, which is expected to scale up the automotive cylinder liner market.
  5. Increasing use of LCVs is likely to help the global automotive cylinder liner market witness high growth during the forecast period.
  6. Cast iron is the most preferred material for automotive cylinder liner, mainly because of its low cost and reduced weight. Additionally, hybrid liner technology serves better functionality and is being majorly adopted by manufacturers.
  7. Prominent value and volume share of the automotive cylinder liner market is predicted to be hold by Asia Pacific excluding Japan.
  8. Middle East & Africa (MEA) is projected to show high growth in terms of value in the global market.
  9. Key market players as well as OEMs are expanding their product offerings by investing in research and development. To counter various situations, manufacturers are focussing on improving the durability by using hybrid materials. Through acquisitions and collaborations, big companies are entering into local markets to further improve the business.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Plasma-derived Protein Therapies Market: Notable Developments & Geographical Outlook

Plasma-derived therapies allow individuals with chronic and life threatening diseases to lead more productive and healthy lives by replacing the missing or deficient proteins. The patients relying on these therapies require regular injections or infusions throughout their lives.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12839

Since the diseases treated by plasma therapies affect a small percentage of the population, they are often considered as rare.  Most of these diseases are genetic and chronic conditions. However, over the years there is a rise in these rare diseases demanding more treatment options.

There have been initiatives to create awareness about the plasma-derived protein therapies and its importance. For instance, CSL Behring and Plasma Protein Therapeutics Association (PPTA’s) other global member companies, In 2018, the PPTA launched a video campaign and called it as “How Is Your Day?”.

The objectives of the campaign were to differentiate traditional from the plasma-derived protein therapies and to highlight the value plasma-derived protein therapies provide to individuals with rare and serious conditions. These initiatives are further expected to boost the growth of the plasma-derived protein therapies market.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12839

Plasma-derived Protein Therapies Market: Drivers and Restraints

Higher volume of immunoglobulin usage in developed countries and strong demand for albumin in Asia pacific is expected to drive the growth of the plasma-derived protein therapies market during the forecast period. Increasing focus and growing investment in innovation is anticipated to propel the growth of the plasma-derived protein therapies market.

For Instance, in March 2016, Grifols announced an investment of US$ 360 Mn to expand its capabilities in the production of plasma-derived therapies. The investment will increase the purification and plasma fractionation capacity of several proteins. Thus leading the plasma-derived protein therapies market towards a significant growth.

In addition, rising incidence of life threatening diseases such as multifocal motor neuropathy (MMN), ideopathic thrombocytopenic purpura (ITP) and other infectious diseases including rabies tetanus, hepatitis A&B, and varicella is also expected to drive the growth of the market.

According to WHO estimates that in 2015, around 257 million were living with chronic hepatitis B infection.However, high cost of these therapies may restrict the growth of the plasma-derived protein therapies market. Moreover, stringent regulations and reimbursement scenario may hamper the plasma-derived protein therapies market during the forecast period.

Plasma-derived Protein Therapies Market: Overview

Based on type, the immunoglobulin segment is expected to account for the largest share due to its beneficial application in treating patients with rare diseases. Additionally, Albumin is also expected to lead considerable growth in this segment owing to its demand in developing countries.

In the application segment, the immunological disorders are expected to hold the highest share due to growing awareness about treatment options provided by plasma-derived therapies.

Based on end user, the hospital segment is expected to have the largest share due to frequent patient visits for diagnosis and treatment of various infectious and immunological disorders.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-12839

Plasma-derived Protein Therapies Market: Regional-Wise Outlook

Geographically, the Plasma-derived protein therapies market is segmented into seven regions, i.e.; Latin America, South Asia, Oceania, East Asia, Europe, North America and Middle East & Africa.

The North America is expected to account for the largest share in the Plasma-derived protein therapies market due to rising geriatric population who are more susceptible to life threatening diseases. According to the U.S Census Bureau, there were 40.3 million U.S. residents 65 years and older in the 2010 census and more than 54 million on July 1, 2019.

Other factors contributing towards the growth of the regional growth of the market in North America is large patient base and well- developed healthcare infrastructure.Asia Pacific is expected to experience fastest growth in the plasma-derived protein therapies market. Increasing demand for advanced treatment option and rise in per capita expenditure are predicted to drive the growth of the market in this region.

Additionally, the increasing focus in the development of healthcare infrastructure in the developing countries is also anticipated to drive the growth of the plasma-derived protein therapies market in Asia Pacific during the forecast period.

Plasma-derived Protein Therapies Market: Key players

Some of the players identified in the Plasma-derived protein therapies market include:

  • CSL Behring LLC
  • Octapharma AG
  • Biotest AG
  • Kedrion S.P.A
  • Bayer AG
  • Grifols S.A.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.

The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology Matrix
  • Value Chain

Gasoline Direct Injection Market is estimated to grow at an exponential rate of over 14% through the forecast period 2021 – 2031

The demand for highly fuel-efficient automotive systems and increasingly stringent emission standards implemented by governments around the world drives the growth of the gasoline direct injection market. The market is estimated to grow at an exponential rate of over 14% through the forecast period 2021 – 2031.

Adoption of gasoline direct injection systems can be largely accounted for by commercial and passenger vehicles, with major manufacturers such as Ford, BMW, Daimler, and more incorporating relevant technologies in mid to high end gasoline vehicles.  Major market players are focused on research towards technology improvements.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5264

Fuel injector systems are estimated to hold major market share owing to the demand for high levels of precision for efficient fuel combustion. Improved control over exhaust emissions and air-fuel mixtures, and real-time monitoring of fuel regulators in terms of delivery pressure will contribute to demand in the long term. This is especially true with the increased incorporation of electronic control units in the automotive sector.Developments in the industry covering flexibility in multiple input and output channels for better signal transfer will aid in the proliferation of gasoline direct injection systems.

Particulate emission reduction research will also gain ground in the near future.Despite high demand in the industry, market players face a number of challenges that could impact sales and revenue in the coming decade. For instance, gasoline direct injection systems are relatively cost-prohibitive owing to the use of high-pressure parts in the system. Furthermore, post combustion particulate emissions remain a challenge for manufacturers. Also, the growing popularity of electric vehicles in the automotive sector is an obstacle that is likely to hinder sales and revenue generation in the market in terms of long-term market prospects.

Key Takeaways in the Gasoline Direct Injection (GDI) Market Study

  • The global gasoline direct injection market will rise at around 14% CAGR between 2021 and 2031.
  • Rapid growth of automotive production rates in China and India, drives a relatively higher rate of growth in the industry of the Asia Pacific excluding Japan market.
  • Steady rise in volume of vehicle production and growing focus on maintenance and aftermarket services have been driving growth in the United States.
  • Following a moderate slump, sales are expected to recover in the Germany and France markets, driven by high fuel economy technologies.
  • Strict implementation of stage 6 emission standards in terms of new vehicle registrations drive adoption and sales of gasoline direct injection technologies in the United Kingdom.

“The global gasoline direct injection (GDI) system market is projected to witness a high growth rate during the forecast period owing to benefits such as improved engine performance, engine downsizing, high fuel efficiency, thermal efficiency, and major reductions in emission volumes, which will continue to gain traction with the imposition of increasingly stringent regulations,” says the FMI analyst.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-5264

Key Segments

Stroke Type

  • 2 Stroke
  • 4 Stroke

Vehicle Type

  • Compact Vehicle
  • Mid-Sized Vehicle
  • Premium Vehicle
  • Luxury Vehicle
  • Commercial Vehicle
  • Heavy Commercial Vehicle

Sales Channel

  • OEM
  • Aftermarket

Direct Purchase of this Report@ https://www.futuremarketinsights.com/checkout/5264

Who is Winning?

The global gasoline direct injection market is moderately fragmented with a number of regional players contributing to the industry. Major players in the market are likely to invest extensively in new technologies and research & development efforts to consolidate their market position.

The gasoline direct injection market is expected to grow exponentially during 2021 to 2031. As a rapidly growing market, companies are likely to gain impetus from changes arising from strict emission standards and regulations being implemented around the world.

Engine Control Unit (ECU) Market is expected to grow at a CAGR of 4.6%, finds Future Market Insights (FMI) in its latest study

Over the forecast period of 2021-2031, the global engine control unit market is expected to grow at a CAGR of 4.6%, finds Future Market Insights (FMI) in its latest study.
The global engine control unit industry is expected to grow significantly throughout the forecast period owing to rising demand for automobiles, technological advancements in the production of low-cost engine control units, and increasing demand for next-generation features in vehicles.
A key element driving the engine control unit market is government restrictions encouraging lower fuel consumption and public demand for better vehicle efficiency.

The expansion of the global engine control unit is due to an increase in vehicle production, government mandates on vehicle fuel economy, and the rising availability of fuel injections. Also, expansion of gasoline market will contribute towards global engine control unit’s growth.
Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5208
Key Takeaways from Market Study

  • By product type, gasoline ECUs are projected to account for more than three-fourth of global sales in terms of volume.
  • c are expected to account for over 70% of engine control unit demand. The increasing demand for better fuel efficiency and focus towards curbing carbon footprint among passenger car owners will support growth in this category.
  • East Asia is estimated to hold more than one third of the global market. The expansion of the automotive sector and the presence of some of the leading manufacturers in this region are driving the market.
  • South Asia Pacific is projected to be the fastest growing market, exhibiting growth at little below 5.5% CAGR.
  • China to account for around one-fourth of the worldwide engine control unit sales.
  • The OEM segment will account for nearly 90% of all the engine control unit sold.

“The demand for engine control units will surge as car sales increase and more people seek improved fuel efficiency and lower emissions. Manufacturers are buoyed by changing consumer behavior to integrate technological advancements. Overall the engine control unit business is predicted to benefit from low-cost parts manufacturing in South and East Asia, as well as the development of new transit corridors,” said a lead analyst at FMI.
Engine Control Unit Market Competitive Landscape
The market has been described as consolidated. Some of the leading market participants included in this report are Robert Bosch GmbH, Denso Corp, Hyundai Motor Company, Hitachi Ltd., United Automotive Electronic Systems Ltd, Mitsubishi Electric Corporation, Marelli Holdings Co., Ltd., Aptiv Plc., Cummins Inc, Cardone Industries Inc, ACDelco, Standard Motor Products Inc., Dorman Products Inc., Electronic Concepts & Engineering Inc., Westport Fuel Systems Inc, aditel Automotive Electronics Ltd. who account for a share of more than 76% of the market.
Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-5208
Key Market Segments Covered
Product Type:

  • Gasoline ECU
  • Diesel ECU
  • Natural Gas ECU

Vehicle Type:

  • Passenger Cars
  • Light Commercial Vehicles
  • Heavy Commercial Vehicles

Sales Channel:

  • OEM
  • Aftermarket

Pre-Book Report@ https://www.futuremarketinsights.com/checkout/5208
Key Points Covered in Engine Control Unit Market Survey

  • Engine control unit market demand outlook for 2021-2031
  • Insights into drivers and restrains affecting ECU sales
  • Engine control unit market category and segment-level analysis
  • Competition mapping and benchmarking
  • Engine control unit manufacturing trend analysis
  • Product Innovations and regulatory climate
  • Post COVID-19 consumer spending on engine control units
  • Recommendation on key winning strategies

Top Reports Related To Automotive Market Insights
Automotive Repair & Maintenance Services Market : Global automotive repair & maintenance services market is forecast to reach a US$ 544.5 Bn in 2021, with a stable long-term projection, as per the latest insights from Future Market Insights (FMI), an ESOMAR-certified research and consulting firm.
Automotive Glass Market : The global demand for automotive glass has declined significantly in 2020, with the Covid-19 pandemic restricting automotive production and reducing new orders in the manufacturing sector. However, long-term prospects remain bullish, with a new report by FMI projecting 4% CAGR through 2030. The report opines that market players will benefit from smart glass technology and the rising popularity of electric vehicles.
About FMI
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
Report: https://www.futuremarketinsights.com/reports/ecu-market
Press Release Source: https://www.futuremarketinsights.com/press-release/ecu-market

Olaparib API Market: Notable Developments & Geographical Outlook

Olaparib is used in treatment of advanced epithelial ovarian cancer, breast cancer and pancreatic cancer. Olaparib with bevacizumab during ovarian cancer chemotherapy.

Olaparib API is a pharmaceutical ingredient used in the manufacturing of Olaparib drug for various disorders like breast cancer, pancreatic cancer, and ovarian cancer. According to the WHO, in 2018 there were around 627,000 women died from breast cancer.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-12835

Rising prevalence of cancer is expected to rise the demand of Olaparib API in the global market.

Moreover, Covid 19 pandemic cause Obstruction in production activities and logistics network disruption occurs due to lockdown implemented in various countries will have short term negative impact on Olaparib API market growth rate.

Beside, treatment adoption and diagnosis rate is reduced owing to decline visits to hospitals and clinics is expected to delay the growth of Olaparib API market. Most of Key players focus on developing coronavirus treatment and diagnostic kits this will hinder Olaparib API market growth.

Pharmaceutical and biopharmaceutical companies shift their focus to develop coronavirus diagnostic kits and treatment option this will hamper growth of Olaparib API market.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-12835

Olaparib API market: Drivers and restraints

Increasing prevalence of breast cancer, ovarian cancer, and prostate cancer is expected to drive the growth of Olaparib API market. The rise in the number of manufacturers and domestic players in the Asia-Pacific region will boost Olaparib API market growth.

Growing Instances of Cancer Patients, drastic change in eating habits and lifestyle propel the risk of disease and hence will increase demand for Olaparib API. Significant adaption of Olaparib API product in Pharmaceutical Products Manufacturing also boost the Olaparib API market growth.

Tremendous increases in healthcare expenditure will propel the Olaparib API market during the forecast period. Introduction to highly advanced and safe active pharmaceutical ingredients will lead to a rise in demand for Olaparib API market in the coming decade.

However, side effects associated with Olaparib API will hinder the Olaparib API market growth over the forecast period. Higher production cost of Olaparib API will hamper overall business growth. Moreover, technology advancement and research and development API leads to potential Threat of Substitutes for Olaparib API.

For any queries linked with the report, ask an analyst
https://www.futuremarketinsights.com/ask-question/rep-gb-12835

Olaparib API market: Overview

Global increase in Olaparib API market consolidation activities such as new setting of new manufacturing facilities or capacity expansion. Olaparib API manufacturing development, mergers & acquisitions, services agreements will aid in substantial market potential.

Moreover Key manufacturers with intent to expand their services and distribution network can look for emerging nations as lucrative markets for investments. Olaparib API therapeutics currently represent the most promise and have experienced the most success within the overall class

Olaparib API market: Region wise outlook

North America is leading due to higher rate of adaption of Olaparib API in treatment of cancer. The USA and Europe have been so far successful in drug development for cancer especially breast cancer and Prostate Cancer. Increasing innovative API therapeutics, investment for research in the fields of cancer to minimize the side effects of Olaparib API.

Other regions are expected to grow in the Olaparib API market due to increasing expenditure on healthcare. Untapped markets in the emerging economies such as Asia and Latin America should be one of the top priority by global Olaparib API manufactures to increase their services and revenue in the market.

Olaparib API market: Key market players

Some of the key market players in Olaparib API market are

  • ScinoPharm Taiwan, Ltd
  • Transo-Pharm USA LLC
  • ALP Pharm Beijing Co.Ltd
  • MSN Laboratories Pvt Ltd
  • Alembic Pharmaceuticals Limited
  • Exelixis Inc
  • Pfizer Inc
  • AstraZeneca plc
  • Novartis AG
  • Bayer AG.

The research report on Olaparib API presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies.

The research report on Olaparib API provides analysis and information according to market segments such as geographies, application, and industry.